Moan J, Christensen T, Sommer S
Cancer Lett. 1982 Feb;15(2):161-6. doi: 10.1016/0304-3835(82)90046-5.
Commercial hematoporphyrin (Hp) and the tumor-localizing and photosensitizing agent hematoporphyrin derivative (Hpd) were analysed by means of high pressure lipid chromatography (HPLC). Furthermore, their efficiencies in sensitizing the photoinactivation of human cells in vitro were compared. The comparison showed that the least polar components of Hpd played the major role in this sensitization. In Hpd solutions used for injection in photochemotherapeutic treatment of cancer, these active components seem to be present as aggregates.
采用高压液相色谱法(HPLC)对商用血卟啉(Hp)以及肿瘤定位和光敏剂血卟啉衍生物(Hpd)进行了分析。此外,还比较了它们在体外使人体细胞光灭活的效率。比较结果表明,Hpd中极性最小的成分在这种致敏作用中起主要作用。在用于癌症光化学治疗的注射用Hpd溶液中,这些活性成分似乎以聚集体形式存在。